A pill that's been in the works since the Carter administration has changed the math on one of the deadliest cancers. In a study of 500 people with advanced pancreatic cancer whose disease had already worsened after one round of treatment, those who took the …
The once-"undruggable" target is KRAS, a gene that fuels most pancreatic cancers and some lung and colorectal cancers. Oncologists called the findings a landmark, though they stress the pill is not a…